Chimeric Therapeutics Share Price and Company Fundamentals
Last traded: Today at 2:02 AM
Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia. The company develops CHM CDH17-directed CAR T cell therapy for the treatment of advanced colorectal cancer, gastric cancer, and intestinal neuroendocrine tumors; and CHM CLTX, a chlorotoxin-directed CAR T cell therapy to treat patients with recurrent or progressive glioblastoma and membrane-bound matrix metalloproteinase-2 (MMP2) expressing solid tumors. It also develops CHM CORE-NK for the treatment of acute myeloid leukaemia/colorectal cancer, acute myeloid cancer, blood cancer, solid tumors, MMP2 expressing solid tumors, and CDH17 expressing solid tumors. The company was incorporated in 2020 and is based in Carlton, Australia.
Key Metrics
PE ratio
-
PB ratio
2.00
Dividend yield
-
Beta
1.49
Market cap
$8.84M
Enterprise value
$751.64K
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://www.chimerictherapeutics.com |
| Mailing address | 62 Lygon Street Level 3 Carlton South Carlton VIC 3053 Australia |
| Phone / Fax | 61 3 9824 5254 / 61 3 9822 7735 |
Dividends
More: Chimeric Therapeutics Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Chimeric Therapeutics paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.CHM dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Chimeric Therapeutics.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Rebecca McQualter | Chief Executive Officer | ||
| Mr. Philip Allen Hains BBus(Acc), C.A., M.B.A. | CFO, Joint Company Secretary & Director | 66 | |
| Dr. Stephanie H. Astrow MBA, Ph.D. | Chief Scientific Officer | 63 | |
| Mr. Nathan Jong C.A. | Joint Company Secretary |
Profitability and management effectiveness
Profit margin
-82.23%
Operating margin
-53.67%
Return on assets
-22.01%
Return on equity
-469.36%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Chimeric Therapeutics is 8.84M and its enterprise value is 751.64K. The enterprise value to revenue ratio of CHM is 0.06. The enterprise value to EBITDA ratio of CHM is -0.14.
The CHM's stocks Beta value is 1.49 making it 49% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Chimeric Therapeutics (CHM)
Chimeric Therapeutics (ASX:CHM) Frequently Asked Questions
1. What is Chimeric Therapeutics's Stock Symbol?
Chimeric Therapeutics trades on ASX under the ticker symbol "CHM".
2. What is Chimeric Therapeutics's stock price today?
One share of CHM stock can currently be purchased for approximately $0.002.
3. How can I contact Chimeric Therapeutics?
Chimeric Therapeutics's mailing address is 62 Lygon Street Level 3 Carlton South Carlton VIC 3053 Australia. The company can be reached via phone at 61 3 9824 5254.
4. What is Chimeric Therapeutics's official website?
The official website of Chimeric Therapeutics is https://www.chimerictherapeutics.com.